MEDPLUS2024-10-012024-12-31 MEDPLUS2024-10-012024-12-31 MEDPLUS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member MEDPLUS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member MEDPLUS2024-12-31 MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue03Member MEDPLUS2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member MEDPLUS2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member MEDPLUS2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue03Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults03Member MEDPLUS2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member MEDPLUS2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member MEDPLUS2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults03Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets03Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member MEDPLUS2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member MEDPLUS2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member MEDPLUS2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member MEDPLUS2024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543427 MEDPLUS NOTLISTED Medplus Health Services Limited Equity 2024-04-01 2025-03-31 2025-01-31 2025-01-08 INR Millions Third quarter 13:30:00 16:30:00 2025-01-31 2025-01-31 Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Consolidated 15614460000.00 125160000.00 15739620000.00 142410000.00 11069080000.00 494330000.00 1896820000.00 259710000.00 624690000.00 686580000.00 15173620000.00 566000000.00 0.00 566000000.00 155180000.00 -47880000.00 107300000.00 0.00 458700000.00 0.00 0.00 0.00 0.00 458700000.00 0.00 458700000.00 458860000.00 -160000.00 458860000.00 -160000.00 239390000.00 2 3.84 3.82 0.00 0.00 3.84 3.82 Notes to the Unaudited consolidated financial results: 1. The above unaudited consolidated financial results of MedPlus Health Services Limited ('the Company') and its subsidiaries (together referred as 'The Group') have been prepared in accordance with Indian Accounting Standards ('Ind AS') prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“listing regulations”) from time to time. These unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on January 31, 2025. These financial results have been subjected to limited review by the Statutory Auditors of the Company and the auditors have expressed and issued an unmodified review report on the same. 2. During the year ended March 31, 2022, the Company has completed its Initial Public Offering (IPO) of 17,573,342 equity shares of face value of Rs. 2 each for cash at an issue price of Rs. 796 per equity share aggregating to Rs. 13,982.95 million, consisting of Fresh Issue of 7,544,511 equity shares amounting to Rs. 6,000 million and an offer for sale of 10,028,831 equity shares amounting to Rs. 7,982.95 million by the Selling Shareholders. Pursuant to the IPO, the equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) with effect from December 23, 2021. The utilization of IPO proceeds received by the Company (net of IPO related expense) is summarized below: (Rs. In Millions) Objects as per Prospectus Planned utilisation as per Prospectus Utilisation up to December 31, 2024 Unutilised amount as on December 31, 2024* i) Investment in Subsidiary - Optival Health Solutions Private Limited towards their working capital requirements 4,671.70 4,671.70 - ii) General Corporate Purposes 1,111.03 448.53 662.50 Total 5,782.73 5,120.23 662.50 * The aforesaid unutilised proceeds of Rs. 662.50 million have been placed as fixed deposits with bank. 3. The earnings per equity share for the quarters and nine months ended are not annualised. 4. During the year ended March 31, 2024, pursuant to an assessment of future profitability of the operations of the Holding Company, the management has recognized deferred tax assets amounting to Rs. 33.59 million on unused business losses and unabsorbed depreciation of earlier years. 5. During the period ended December 31, 2024, the Company received an approval from National Company Law Tribunal for the proposed merger of its wholly owned subsidiary, MHS Pharmaceuticals Private Limited with the Company. 6. The above financial results are also available at the Stock Exchange's website i.e. www.bseindia.com, www.nseindia.com and the Company's website www.medplusindia.com. For and on behalf of the Board of Directors of MedPlus Health Services Limited G. Madhukar Reddy Managing Director and Chief Executive Officer DIN: 00098097 Place: Hyderabad Date: January 31, 2025 Multi segment 2024-04-01 2024-12-31 Unaudited Consolidated 46264440000.00 328240000.00 46592680000.00 421730000.00 34357600000.00 540910000.00 5318460000.00 757450000.00 1856340000.00 2118460000.00 45370950000.00 1221730000.00 0.00 1221730000.00 352600000.00 -120000000.00 232600000.00 0.00 989130000.00 0.00 0.00 0.00 0.00 989130000.00 0.00 989130000.00 989870000.00 -740000.00 989870000.00 -740000.00 239390000.00 2 8.28 8.24 0.00 0.00 8.28 8.24 Other Expenses 686580000.00 Other Expenses 2118460000.00 a. Retail 15338870000.00 b. Diagnostic services 274670000.00 c. Others 920000.00 a. Retail 45457290000.00 b. Diagnostic services 800240000.00 c. Others 6910000.00 15614460000.00 46264440000.00 15614460000.00 46264440000.00 a. Retail 536610000.00 b. Diagnostic services -24540000.00 c. Others -500000.00 a. Retail 1208140000.00 b. Diagnostic services -100720000.00 c. Others 2440000.00 511570000.00 1109860000.00 0.00 0.00 -54430000.00 -111870000.00 566000000.00 1221730000.00 a. Retail 26134750000.00 b. Diagnostic services 1473700000.00 c. Others 4722610000.00 32331060000.00 0.00 32331060000.00 a. Retail 14450110000.00 b. Diagnostic services 1004210000.00 c. Others 3500000.00 15457820000.00